Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.

  title={Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.},
  author={Xiaofang Sun and Xiaohua Niu and Ruochan Chen and Wenyin He and De Chen and Rui Kang and Daolin Tang},
  volume={64 2},
UNLABELLED Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide and currently has the fastest rising incidence of all cancers. Sorafenib was originally identified as an inhibitor of multiple oncogenic kinases and remains the only approved systemic therapy for advanced HCC. However, acquired resistance to sorafenib has been found in HCC patients, which results in poor prognosis. Here, we show that metallothionein (MT)-1G is a critical regulator and promising… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 29 extracted citations

Role of ferroptosis in hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology • 2018


Publications referenced by this paper.
Showing 1-10 of 47 references

Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha.

Proceedings of the National Academy of Sciences of the United States of America • 2007
View 6 Excerpts
Highly Influenced

Cancer statistics, 2016.

CA: a cancer journal for clinicians • 2016
View 1 Excerpt

Ferroptosis: Death by Lipid Peroxidation.

Trends in cell biology • 2016
View 2 Excerpts

Ferroptosis: process and function

Cell Death and Differentiation • 2016
View 3 Excerpts

Similar Papers

Loading similar papers…